F&C Managed Portfolio has announced results for the six months that finished on 30 November 2014. The FTSE All-Share Index returned -0.1% over that period but F&C Managed Portfolio Growth shares (FMPG) returned 4.3% and the F&C Managed Portfolio Income shares (FMPI) returned 3.0% over the period. This may be largely down to a good period for investment companies generally as the FTSE Equity Investment Instruments Index (an index of investment trusts) returned 5.6%. The Income shares got two dividends of 1.15p in the period (up from 1.1p in the previous year).
The best performing funds in the growth portfolio were Biotech Growth Trust (BIOG) and Worldwide Healthcare (WWH) on the back of the popularity of the healthcare sector and Scottish Mortgage (SMT) and Polar Capital Technology (PCT) on the back of a strong performance by technology stocks.
In the income portfolio, the biotech story also played its part in the form of an investment in Swiss-listed BB Biotech. The manager also mentions a good contribution from Schroder Real Estate (SREI).
Holdings in BlackRock Commodities Income (BRCI) and BlackRock World Mining (BRWM) were hit by falling commodity prices and were sold.
FMPG / FMPI : F&C Managed Portfolio benefits from strong investment company sector